InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Satvat Ali J.. Officer active across 1 company, notably BridgeBio Pharma, Inc.. Aggregated, 3 reports have been published. History available since 30 December 2024. The latest transaction was disclosed on 30 December 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
3 of 3 declarations